Published in Scand J Rheumatol on January 01, 1995
Management of septic arthritis: a systematic review. Ann Rheum Dis (2007) 1.37
Rheumatic disease presenting as septic arthritis: a report of 10 cases. Rheumatol Int (2012) 0.79
Can L(+)-lactate be used as a marker of experimentally induced inflammation in rats? Inflamm Res (2009) 0.78
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
Hospital outbreak of Yersinia enterocolitica infection. Lancet (1973) 2.56
Persistence of IgM, IgG, and IgA antibodies to Yersinia in yersinia arthritis. J Infect Dis (1980) 2.45
Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev (1985) 2.22
An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis (1984) 2.14
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
Bursal and postbursal stem cells in chicken. Functional characteristics. Eur J Immunol (1973) 1.74
Lisfranc joint injuries: trauma mechanisms and associated injuries. J Trauma (1993) 1.73
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.61
Bone bank service in Finland. Experience of bacteriologic, serologic and clinical results of the Turku Bone Bank 1972-1995. Acta Orthop Scand (1998) 1.56
Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52
Synovial T lymphocyte recognition of organisms that trigger reactive arthritis. Clin Exp Immunol (1989) 1.49
Serologic evidence of Yersinia infection in patients with anterior uveitis. Arch Ophthalmol (1990) 1.48
Virulence-plasmid is associated with the inhibition of opsonization in Yersinia enterocolitica and Yersinia pseudotuberculosis. Clin Exp Immunol (1987) 1.36
IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis. Ann Rheum Dis (1986) 1.35
Measurement of immunoglobulin M, immunoglobulin G, and immunoglobulin A antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: comparison of lipopolysaccharide and whole bacterium as antigen. J Clin Microbiol (1981) 1.31
Complete restoration of bursa-dependent immune system after transplantation of semiallogeneic stem cells into immunodeficient chicks. J Exp Med (1974) 1.29
Uptake of environmental antigens by the bursa of Fabricius. Nature (1975) 1.23
Circulating yersinia specific immune complexes after acute yersiniosis: a follow up study of patients with and without reactive arthritis. Ann Rheum Dis (1987) 1.22
Clinical manifestations of Yersinia pseudotuberculosis infection in children. Eur J Clin Microbiol Infect Dis (1989) 1.22
Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora. Chemotherapy (1976) 1.20
Ontogeny of bursal function in chicken. 3. Immunocompletent cell for humoral immunity. J Exp Med (1972) 1.20
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Bacterial antigens in synovial biopsy specimens in yersinia triggered reactive arthritis. Ann Rheum Dis (1991) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
Immunoblot analysis of human IgM, IgG and IgA responses to plasmid-encoded antigens of Yersinia enterocolitica serovar O3. J Med Microbiol (1987) 1.14
The effect of rigidity on fracture healing in external fixation. Clin Orthop Relat Res (1989) 1.12
Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol (1992) 1.11
Nomenclature for chicken major histocompatibility (B) complex. Immunogenetics (1982) 1.08
Stress fracture of the ulnar diaphysis in a recreational golfer. Clin J Sport Med (1997) 1.08
Pore diameter of more than 100 microm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res (2001) 1.08
Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med (2004) 1.07
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Protein phosphatase inhibition in normal and keratin 8/18 assembly-incompetent mouse strains supports a functional role of keratin intermediate filaments in preserving hepatocyte integrity. Hepatology (1998) 1.04
Ontogeny of bursal function in chicken. I. Embryonic stem cell for humoral immunity. J Immunol (1972) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Acute anterior uveitis after yersinia infection. Br J Ophthalmol (1982) 1.01
Restriction map of virulence plasmid in Yersinia enterocolitica O:3. Plasmid (1986) 1.01
HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.01
Gene expression during bone repair. Clin Orthop Relat Res (1993) 1.00
Levamisole and agranulocytosis. Lancet (1976) 1.00
Antibody response in Yersinia pseudotuberculosis III infection: analysis of an outbreak. J Infect Dis (1987) 0.98
Yersinia-associated arthritis in the rat: experimental model for human reactive arthritis? Acta Pathol Microbiol Immunol Scand C (1986) 0.98
Avidity of anti-Yersinia antibodies in yersiniosis patients with and without Yersinia-triggered reactive arthritis. Arthritis Rheum (1987) 0.97
Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis (2000) 0.97
Detection of circulating Yersinia-immunoglobulin complexes by enzyme immunoassay (EIA). J Immunol Methods (1986) 0.96
Fatal influenza A myocarditis with isolation of virus from the myocardium. Acta Med Scand (1983) 0.96
In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection. Clin Exp Rheumatol (1985) 0.95
Incorporation and clinical results of large allografts of the extremities and pelvis. Clin Orthop Relat Res (1994) 0.95
Bacterial PCR in the diagnosis of joint infection. Ann Rheum Dis (2001) 0.95
Molecular basis for action of bioactive glasses as bone graft substitute. Scand J Surg (2006) 0.95
Managing reactive arthritis. Rheumatology (Oxford) (2000) 0.95
Lymphocyte transformation responses to gram negative bacteria after Yersinia and Salmonella infection: the importance of enterobacterial common antigen for the response. J Rheumatol (1984) 0.94
Selective activation of chicken T lymphocytes by concanavalin A. J Immunol (1973) 0.94
Monoclonal antibodies reacting selectively with core and O-polysaccharide of Yersinia enterocolitica O:3 lipopolysaccharide. Acta Pathol Microbiol Immunol Scand C (1987) 0.94
Ontogeny of bursal function in chicken. II. Postembryonic stem cell for humoral immunity. J Immunol (1972) 0.94
Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop Relat Res (1993) 0.94
Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int (2000) 0.93
Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum (1996) 0.92
Biological responses of silver-coated thermosets: an in vitro and in vivo study. Acta Biomater (2012) 0.92
Oncoprotein expression in human synovial tissue: an immunohistochemical study of different types of arthritis. Br J Rheumatol (1996) 0.92
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS (2001) 0.92
Effects of axial dynamization on bone healing. J Trauma (1993) 0.91
Analysis of IgA antibodies to lipopolysaccharide in Yersinia-triggered reactive arthritis. J Infect Dis (1989) 0.91
Yersiniosis as a gastrointestinal disease. Scand J Infect Dis (1987) 0.91
Yersinia arthritis in children. Scand J Rheumatol (1980) 0.91
Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin. Br J Rheumatol (1997) 0.90
Differences between female and male patients with familial rheumatoid arthritis. Ann Rheum Dis (2001) 0.90
Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis. Ann Rheum Dis (1983) 0.90
Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J Bone Miner Res (1999) 0.90
Synovial fluid muramic acid in acute inflammatory arthritis. Br J Rheumatol (1994) 0.90
Development of a multi-component fiber-reinforced composite implant for load-sharing conditions. Med Eng Phys (2008) 0.90
The influence of anaesthetic technique upon the immune response to hysterectomy. A comparison of propofol infusion and isoflurane. Anaesthesia (1995) 0.89
Carrier proteins of folic acid activity in human serum. Acta Haematol (1971) 0.89
Factors associated with the development of reactive arthritis. Br J Rheumatol (1988) 0.89
Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Bone (2005) 0.89
ELISA and RIA for serologic diagnosis of yersiniosis. Rev Infect Dis (1984) 0.89
Local challenge on oral mucosa with an alpha-gliadin related synthetic peptide in patients with celiac disease. Am J Gastroenterol (2000) 0.89
Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci? Lancet (1978) 0.88
Immunoblot analysis of IgM, IgG, and IgA responses to plasmid encoded released proteins of Yersinia enterocolitica in patients with or without yersinia triggered reactive arthritis. Ann Rheum Dis (1989) 0.88
High frequency of Yersinia antibodies in healthy populations in Finland and Germany. Rheumatol Int (1997) 0.88
Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Ann Rheum Dis (2000) 0.88
Avidity of antibodies against released proteins of Yersinia spp: comparison of patients with or without reactive arthritis. Ann Rheum Dis (1989) 0.87
Barbiturate anesthesia and brain proton spectroscopy. AJNR Am J Neuroradiol (1999) 0.87
Intramedullary fixation of high subtrochanteric femoral fractures: a study comparing two implant designs, the Gamma nail and the intramedullary hip screw. J Orthop Trauma (1998) 0.87
Alkaline phosphatase in the developing bursa of Fabricius. A comparative study of the cyclophosphamide- and testosterone-induced immunodeficiencies in the chick embryo. Scand J Immunol (1977) 0.87
Creation of microrough surface on sintered bioactive glass microspheres. J Biomed Mater Res (2001) 0.86
Density gradient separation of chicken thymus cells. Eur J Immunol (1973) 0.86
RSA applications in monitoring of fracture healing in clinical trials. Scand J Surg (2006) 0.86
Bursal and postbursal cells in chicken. Occurrence of postbursal cells in bone marrow, thymus and spleen. Eur J Immunol (1974) 0.86
Effect of platelet count on serum and plasma potassium: evaluation using database information from two hospitals. Scand J Clin Lab Invest Suppl (1995) 0.85
Combined use of released proteins and lipopolysaccharide in enzyme-linked immunosorbent assay for serologic screening of Yersinia infections. J Infect Dis (1991) 0.85
Role of antibodies in the opsonization of Yersinia spp. Infect Immun (1988) 0.85
Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis (2003) 0.85
Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 0.85
Cysteine proteinases in chondrosarcomas. Matrix Biol (2001) 0.85
Tumour necrosis factor microsatellites in reactive arthritis. Br J Rheumatol (1998) 0.85